Research Article

Evaluation of SLE Susceptibility Genes in Malaysians

Table 1

SLE susceptibility genes in Malay (MA) and Chinese (CH).

GeneCytogenetic bandSNPBase positionA1/A2ChineseMalayMeta-analysis value*
F_A
F_U
value
OR
95% CI
F_A
F_U
value
OR
95% CI

TNFSF4-LOC7300701q25rs10798269173,309,713A/G0.3420.401 0.78 (0.61–0.99)0.3140.460 0.54 (0.32–0.9)
NCF21q25rs13306575183,532,437T/C0.0800.043 1.95 (1.18–3.22)0.1190.070 1.78 (0.74–4.28)
MAPKAPK2-IL101q31-32rs2232360207,040,659A/G0.3280.351 0.9 (0.71–1.15)0.5760.397 2.07 (1.24–3.45)
RASGRP32p25.1-24.1rs1342599933,702,203T/C0.1290.174 0.7 (0.51–0.97)0.1020.203 0.44 (0.21–0.93)
IFIH12q24rs13023380163,154,363A/G0.0100.002 6.14 (0.74–51.13)0.0250.103 0.23 (0.06–0.82)
STAT42q32.2-32.3rs7568275191,966,452G/C0.4530.317 1.78 (1.4–2.27)0.4220.236 2.36 (1.33–4.19)
BANK14q24rs17031870102,940,788G/A0.0920.058 1.64 (1.05–2.56)0.2370.143 1.87 (0.97–3.59)
TNIP15q32-33.1rs3792782150,456,677C/T0.2140.247 0.83 (0.63–1.09)0.3050.453 0.53 (0.31–0.89)
HLA-DRA6p21.3rs691177732,409,996C/T0.2640.137 2.26 (1.67–3.05)0.1610.055 3.32 (1.34–8.21)
PRDM1-ATG56q21rs9398065106,546,034C/G0.0750.039 1.97 (1.17–3.31)0.1190.039 3.31 (1.15–9.5)
TNFAIP36q23rs5029928138,189,942T/C0.0830.046 1.88 (1.15–3.05)0.0590.031 1.96 (0.56–6.86)
C7orf721-IKZF17p13-11.1rs1118560350,306,810G/C0.2360.282 0.79 (0.61–1.03)0.1440.302 0.39 (0.21–0.74)
BLK8p23-22rs1178237511,294,934C/T0.2770.380 0.62 (0.49–0.8)0.2970.375 0.7 (0.41–1.2)
LYN8q13rs782825856,867,945T/C0.2230.242 0.9 (0.68–1.18)0.1360.281 0.4 (0.21–0.77)
KIAA1542-PHRF111p15.5rs4963128589,564T/C0.0830.070 1.2 (0.78–1.86)0.0590.156 0.34 (0.14–0.84)
IRF711p15.5rs7943546612,148C/T0.0240.033 0.74 (0.37–1.49)0.0250.055 0.45 (0.11–1.79)
PDHX-CD4411p13rs1236214035,142,019A/C0.0070.027 0.25 (0.08–0.75)0.0850.148 0.53 (0.24–1.2)
ETS111q23.3rs76404385128,333,055T/C0.2020.138 1.59 (1.16–2.17)0.1780.063 3.25 (1.38–7.65)
SLC15A412q24.32rs6486738129,432,715G/C0.2950.337 0.82 (0.64–1.05)0.2030.305 0.58 (0.32–1.05)
IL21R16p11rs806036827,412,414T/C0.0120.039 0.3 (0.13–0.71)0.1700.109 1.66 (0.8–3.46)
ITGAM16p11.2rs1244471331,378,235A/G0.2840.369 0.68 (0.53–0.87)0.50.52 1.1 (0.67–1.82)
ORF8-LOC10013195216q24.1rs3491223886,001,903T/C0.0390.077 0.49 (0.29–0.82)0.0760.031 2.56 (0.77–8.55)
ICAM1-ICAM419p13.2rs549810,395,683G/A0.2500.267 0.91 (0.7–1.19)0.3140.242 1.43 (0.82–2.51)
TYK219p13.2rs1297559110,627,814G/A0.4150.454 0.85 (0.67–1.08)0.2320.121 2.19 (1.09–4.41)
UBE2L322q11.21rs223664221,989,621T/C0.0890.127 0.67 (0.46–0.98)0.1440.172 0.81 (0.41–1.62)

When ORs from CH and MA are in different directions, we did not perform the meta-analysis.
— indicated SNPs where no meta-analysis was performed.
OR: odds ratio. Minor allele frequencies are given for the minor allele A1. F_A: minor allele frequency for cases; F_U: minor allele frequency for controls.